Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.
Eschbach RS, Fendler WP, Kazmierczak PM, Hacker M, Rominger A, Carlsen J, Hirner-Eppeneder H, Schuster J, Moser M, Havla L, Schneider MJ, Ingrisch M, Spaeth L, Reiser MF, Nikolaou K, Cyran CC.
Eschbach RS, et al. Among authors: kazmierczak pm.
PLoS One. 2015 Feb 10;10(2):e0115543. doi: 10.1371/journal.pone.0115543. eCollection 2015.
PLoS One. 2015.
PMID: 25668193
Free PMC article.